PartnerUpdated October 2026Blended formulas, term unstatedMyDrHank review
Three compounded GLP-1 products, each blended with a second ingredient, and a starting monthly figure on every one with no plan length printed beside it.
The verdict
MyDrHank sells compounded tirzepatide from $240 a month, a compounded semaglutide injection from $178 and a daily semaglutide tablet from $171. Each figure is printed as a starting price, and none of the three product pages names the dose it buys or how long a plan has to run to get it. The consultation and the delivery are both advertised as free, which takes two common charges off the table before the first month begins.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $178/mo
- Oral
- From $171/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- LegitScript
- Claimed by provider
MyDrHank is a telehealth platform covering weight, sexual health, hair loss and longevity. Its weight-loss shelf holds three compounded GLP-1 products: a weekly tirzepatide injection, a weekly semaglutide injection and a daily semaglutide tablet. The injections come in two versions, one compounded with vitamin B-12 and one with the amino acid glycine, and the product pages say both carry the same active ingredient at the same dose. The tablet is compounded with a low dose of ondansetron, an anti-nausea drug, which the seller says is there to help patients stay on therapy through the early weeks. The site says it has treated more than 10,000 patients.
Who writes the prescription, and what do they see?
A U.S.-licensed clinician reads an online questionnaire of roughly five minutes and writes a prescription only when it is judged appropriate. The terms add that providers hold licenses in the states where they treat, and that a completed intake may still end without any prescription at all. No clinician is named on the weight-loss pages. The terms also state that using the service does not create a provider-patient relationship with the platform itself, which places MyDrHank as the company that arranges the visit rather than the one practicing medicine.
The intake lays out three stages, from creating an account to a physician's review to a shipment at the door. After that, the homepage promises check-ins, dose adjustments and unlimited messaging with a care team for as long as treatment lasts. Refills and what the reorder page calls subscription changes go through that team by email or phone, with a reply promised within one business day. Nothing in the terms of use covers how a plan renews, how it is canceled, or whether a shipped order can be refunded, so those answers have to come from the care team before the first charge.
What happens when the dose goes up?
The semaglutide page sketches the first half-year as a timeline, calling months two through five the dose-escalation phase and saying the provider reviews and adjusts the dose in weeks eight through sixteen. The tablet page says most patients have reached a maintenance dose somewhere between weeks eight and twelve. The ondansetron in the tablet is the one part of the plan built for those weeks, since the seller names nausea as the most common side effect early on. What none of the three pages says is whether the starting figure holds as the dose climbs, because no milligram amount is printed beside any price.
What the price includes
The three figures, $240 for tirzepatide, $178 for the semaglutide injection and $171 for the tablet, are each introduced with the word From and a per-month sign. The B-12 and glycine versions of each injection show the same amount. No plan length, dose ladder or month-two price sits beside them, so the public pages leave open whether the starting figure is a month-to-month rate or one tied to a longer plan. The homepage places the words No commitment next to the button that opens the questionnaire. No insurance is required, the consultation is advertised as free, and the product pages say shipping is included.
What it claims, and what it cites
All three GLP-1 products are compounded, and the site's own footer says compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. The product pages say they are prepared in FDA-registered U.S. pharmacies, but none is named. The terms say a current list of pharmacy partners is available on request, and they warn that orders do not come in child-resistant packaging. The weight-loss calculators project results from trials of the branded drugs, and the footnotes beneath them say results with the compounded versions may differ.
Where it holds up, and where it does not
- Strength: Free consultation and free delivery advertised
- Strength: Two injection formulas at one price
- Strength: Anti-nausea drug compounded into the tablet
- Strength: LegitScript seal displayed on the site
- Limitation: Every price is a From figure with no term
- Limitation: No dose printed beside any price
- Limitation: Pharmacy partners named only on request
- Limitation: No renewal, cancellation or refund terms published
What the evidence says about this kind of treatment
The assessment above is about MyDrHank. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone who expects nausea to be the hard part of the first months, wants a tablet built around that, and is prepared to ask about the plan length before paying.
- Wrong for
- A reader who wants the month-two price, the plan length and the name of the pharmacy settled before starting an account.
How MyDrHank compares
| Seller | Who it suits | Go |
|---|---|---|
 Revel Health | A reader who wants an oral and expects to pay less for it, which on this seller is what happens. | See Revel Health → |
| Luci | Readers who take an asterisk seriously and plan to ask what it hides | See Luci → |
 TrimRx | Readers who already know which molecule they want and will hunt for which tile holds it | See TrimRx → |
More GLP-1 telehealth sellers reviews: Fitness RXFitRxFitstryFMmedsFORMFormBlends
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Do the B-12 and glycine versions cost the same?
- Yes. Both versions of the tirzepatide injection show a starting figure of $240 a month, both semaglutide versions show $178, and the pages say each pair carries the same active ingredient at the same dose.
- How long does a plan run at the starting price?
- The product pages do not say. Each figure reads From, per month, with no plan length, dose or later-month rate printed beside it.
- Which pharmacy fills the prescription?
- None is named on the site. The product pages describe an FDA-registered U.S. pharmacy, and the terms say a current list of pharmacy partners is available on request.
- Is MyDrHank expensive compared with other GLP-1 telehealth sellers?
- MyDrHank publishes a starting figure of $171/mo. Across the 397 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $189, which puts MyDrHank below the median, toward the cheaper end. The other 61 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.